Proliferation and migration of PC-3 prostate cancer cells is counteracted by PPARγ-cladosporol binding-mediated apoptosis and a decreased lipid biosynthesis and accumulation

被引:3
作者
Rapuano, Roberta [1 ]
Riccio, Alessio [1 ]
Mercuri, Antonella [1 ]
Madera, Jessica Raffaella [1 ]
Dallavalle, Sabrina [2 ]
Moricca, Salvatore [3 ]
Lupo, Angelo [1 ]
机构
[1] Univ Sannio, Dipartimento Sci & Tecnol, Via Mulini,42, I-82100 Benevento, Italy
[2] Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, via Celoria 2, I-20133 Milan, Italy
[3] Univ Firenze, Dipartimento Sci & Tecnol Agrarie Alimentari Ambie, Piazzale Cascine 28, I-50144 Florence, Italy
关键词
Cladosporols; PPAR gamma agonists; Proliferation; Migration; Apoptosis; Lipogenesis; ACTIVATED RECEPTOR-GAMMA; ANDROGEN-RECEPTOR; LINES CHARACTERISTICS; NATURAL-PRODUCTS; SUPPRESSOR; DIAGNOSIS; VARIANTS; PROGRAM; LIGAND; GENES;
D O I
10.1016/j.bcp.2024.116097
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Chemoprevention, consisting of the administration of natural and/or synthetic compounds, appears to be an alternative way to common therapeutical approaches to preventing the occurrence of various cancers. Cladosporols, secondary metabolites from Cladosporium tenuissimum, showed a powerful ability in controlling human colon cancer cell proliferation through a peroxisome proliferator-activated receptor gamma (PPAR gamma)mediated modulation of gene expression. Hence, we carried out experiments to verify the anticancer properties of cladosporols in human prostate cancer cells. Prostate cancer represents one of the most widespread tumors in which several risk factors play a role in determining its high mortality rate in men. Materials and methods: We assessed, by viability assays, PPAR gamma silencing and overexpression experiments and western blotting analysis, the anticancer properties of cladosporols in cancer prostate cell lines. Results: Cladosporols A and B selectively inhibited the proliferation of human prostate PNT-1A, LNCaP and PC-3 cells and their most impactful antiproliferative ability towards PC-3 prostate cancer cells, was mediated by PPAR gamma modulation. Moreover, the anticancer ability of cladosporols implied a sustained apoptosis. Finally, cladosporols negatively regulated the expression of enzymes involved in the biosynthesis of fatty acids and cholesterol, thus enforcing the relationship between prostate cancer development and lipid metabolism dysregulation. Conclusion: This is the first work, to our knowledge, in which the role of cladosporols A and B was disclosed in prostate cancer cells. Importantly, the present study highlighted the potential of cladosporols as new therapeutical tools, which, interfering with cell proliferation and lipid pathway dysregulation, may control prostate cancer initiation and progression.
引用
收藏
页数:19
相关论文
共 56 条
  • [1] DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: Implications for the androgen receptor functions and regulation
    Alimirah, F
    Chen, JM
    Basrawala, Z
    Xin, H
    Choubey, D
    [J]. FEBS LETTERS, 2006, 580 (09): : 2294 - 2300
  • [2] Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
    Chen, Jingjing
    Guccini, Ilaria
    Di Mitri, Diletta
    Brina, Daniela
    Revandkar, Ajinkya
    Sarti, Manuela
    Pasquini, Emiliano
    Alajati, Abdullah
    Pinton, Sandra
    Losa, Marco
    Civenni, Gianluca
    Catapano, Carlo V.
    Sgrignani, Jacopo
    Cavalli, Andrea
    D'Antuono, Rocco
    Asara, John M.
    Morandi, Andrea
    Chiarugi, Paola
    Crotti, Sara
    Agostini, Marco
    Montopoli, Monica
    Masgras, Ionica
    Rasola, Andrea
    Garcia-Escudero, Ramon
    Delaleu, Nicolas
    Rinaldi, Andrea
    Bertoni, Francesco
    de Bono, Johann
    Carracedo, Arkaitz
    Alimonti, Andrea
    [J]. NATURE GENETICS, 2018, 50 (02) : 219 - +
  • [3] An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
    Chen, Ming
    Zhang, Jiangwen
    Sampieri, Katia
    Clohessy, John G.
    Mendez, Lourdes
    Gonzalez-Billalabeitia, Enrique
    Liu, Xue-Song
    Lee, Yu-Ru
    Fung, Jacqueline
    Katon, Jesse M.
    Menon, Archita Venugopal
    Webster, Kaitlyn A.
    Ng, Christopher
    Palumbieri, Maria Dilia
    Diolombi, Moussa S.
    Breitkopf, Susanne B.
    Teruya-Feldstein, Julie
    Signoretti, Sabina
    Bronson, Roderick T.
    Asara, John M.
    Castillo-Martin, Mireia
    Cordon-Cardo, Carlos
    Pandolfi, Pier Paolo
    [J]. NATURE GENETICS, 2018, 50 (02) : 206 - +
  • [4] Cheng HH, 2019, Genetic risk factors for prostate cancer
  • [5] Natural products: A continuing source of novel drug leads
    Cragg, Gordon M.
    Newman, David J.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2013, 1830 (06): : 3670 - 3695
  • [6] Biochemical and Biological Attributes of Matrix Metalloproteinases
    Cui, Ning
    Hu, Min
    Khalil, Raouf A.
    [J]. MATRIX METALLOPROTEINSES AND TISSUE REMODELING IN HEALTH AND DISEASE: CARDIOVASCULAR REMODELING, 2017, 147 : 1 - 73
  • [7] Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer
    Daniyal, Muhammad
    Siddiqui, Zamir Ali
    Akram, Muhammad
    Asir, H. M.
    Sultana, Sabira
    Khan, Asmatullah
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (22) : 9575 - 9578
  • [8] Fundamentals of cancer metabolism
    DeBerardinis, Ralph J.
    Chandel, Navdeep S.
    [J]. SCIENCE ADVANCES, 2016, 2 (05):
  • [9] Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
    Dehm, Scott M.
    Schmidt, Lucy J.
    Heemers, Hannelore V.
    Vessella, Robert L.
    Tindall, Donald J.
    [J]. CANCER RESEARCH, 2008, 68 (13) : 5469 - 5477
  • [10] PPARγ2 functions as a tumor suppressor in a translational mouse model of human prostate cancer
    Dong, Fu-Lu
    Liu, Dong-Mei
    Lu, Ting-Ting
    Li, Feng
    Zhang, Chong
    Qun, E.
    Zhang, Yong-Hui
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2022, 24 (01): : 90 - +